Doctors

Cancer Tissue Cryopreservation & Advanced Testing

SpeciCare helps clinicians preserve viable tumor tissue via cryopreservation, enabling advanced genomic, ex-vivo drug sensitivity testing, immunotherapy biomarkers, and clinical trial readiness—without adding workflow burden.

Tissue Cryopreservation

  • Why Cryopreserve?
  • The process
  • How to order

Advanced Testing

  • Treatment Effectiveness Testing
  • Genomic analysis
  • Immunotherapy
  • Personalized vaccines
  • Clinical trials

SpeciCare Cancer Tissue Management Network

  • Join one of SpeciCare’s clinical trials
  • Participate in advanced research & testing

Clinicians

Preserve viable tumor tissue for advanced testing, clinical trials, and precision treatment pathways.

SpeciCare helps clinicians and pathology teams preserve viable tumor tissue—so today’s biopsy can support tomorrow’s decisions. Standard FFPE remains essential for histopathology, but formalin fixation introduces chemical modification, fragmentation, and crosslinking that can constrain downstream molecular and multi-omics use, especially for RNA-based applications and some advanced platforms. (PMC)

Cryopreservation (viable tissue preservation) adds optionality: it enables future-ready workflows including high-quality nucleic acid analysis, select proteomic approaches, and emerging single-cell/multi-omics assays that benefit from viable or appropriately preserved cellular material. (PMC)